Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review-Reference-Cited by-同舟云学术

Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review

Published:2024-02-09 Issue:2 Volume:12 Page:187-195
ISSN:2281-7565
Container-title:Clinical and Translational Imaging
language:en
Short-container-title:Clin Transl Imaging

Author:

Nadaraja Sambavy^ORCID,Helsing Jonas,Naghavi-Behzad Mohammad^ORCID,Land Lotte H.^ORCID,Ruhlmann Christina H.^ORCID,Gerke Oke^ORCID,Hildebrandt Malene G.^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40336-024-00618-3.pdf

Reference43 articles.

1. Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A et al (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375:1823–1833. https://doi.org/10.1056/NEJMoa1606774

2. Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A et al (2021) Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score ≥ 50. J Clin Oncol 39:2339–2349. https://doi.org/10.1200/jco.21.00174

3. Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Lao CD et al (2019) Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med 381:1535–1546. https://doi.org/10.1056/NEJMoa1910836

4. Swetter SM, Thompson JA, Albertini MR, Barker CA, Baumgartner J, Boland G et al (2021) NCCN Guidelines® insights: melanoma: cutaneous, version 2.2021. J Natl Compr Cancer Netw 19:364–376. https://doi.org/10.6004/jnccn.2021.0018

5. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A et al (2021) NCCN guidelines insights: non-small cell lung cancer, version 2.2021. J Natl Compr Cancer Netw 19:254–266. https://doi.org/10.6004/jnccn.2021.0013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction: Value of 2-[18 F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review;Clinical and Translational Imaging;2024-05-13